Investigation of the association between mitochondrial DNA and p53 gene mutations in transitional cell carcinoma of the bladder

Oncology Letters

Volumn 12, Issue 4, 2016, Pages 2872-2879

  Avcilar, Tuba ^a   Kirac, Deniz ^b   Ergec, Deniz ^a   Koc, Gulsah ^c   Ulucan, Korkut ^a   Kaya, Zehra ^d   Kaspar, Elif Cigdem ^b   Turkeri, Levent ^a   Guney, Ahmet Ilter ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ISTANBUL AYDIN UNIVERSITY   (Turkey)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Bladder carcinoma; MtDNA; P53; TCC

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYTOCHROME B; MITOCHONDRIAL DNA; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DNA DAMAGE; DNA EXTRACTION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSITIONAL CELL CARCINOMA;

EID: 84983431662     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5000     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global Cancer Statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T and Terada M: Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52: 1393-1398, 1992.
3. Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD and Smith ND: Bladder cancer risk from occupational and environmental exposures. Urol Oncol 30: 199-211, 2012.
4. Williams SG and Stein JP: Molecular pathways in bladder cancer. Urol Res 32: 373-385, 2004.
5. Lin HY, Huang CH, Wu WJ, Chou YH, Fan PL and Lung FW: Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan. Kaohsiung J Med Sci 21: 57-64, 2005.
6. Berggren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkström H and Hemminki K: p53 mutations in urinary bladder cancer. Br J Cancer 84: 1505-1511, 2001.
7. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
8. Lorenzo Romero JG, Salinas Sánchez AS, Giménez Bachs JM, Sánchez Sánchez F, Escribano Martínez J, Hernández Millán IR, Segura Martín M and Virseda Rodríguez JA: p53 Gene mutations in superficial bladder cancer. Urol Int 73: 212-218, 2004.
9. Chen GF, Chan FL, Hong BF, Chan LW and Chan PS: Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer. Oncol Rep 12: 463-472, 2004.
10. Wada T, Tanji N, Ozawa A, Wang J, Shimamoto K, Sakayama K and Yokoyama M: Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers. Anticancer Res 26: 3403-3408, 2006.
11. Dasgupta S, Hoque MO, Upadhyay S and Sidransky D: Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68: 700-706, 2008.
12. Carew JS and Huang P: Mitochondrial defects in cancer. Mol Cancer 1: 9, 2002.
13. Chang SC, Lin PC, Yang SH, Wang HS, Liang WY and Lin JK: Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis 24: 623-628, 2009.
14. Gochhait S, Bhatt A, Sharma S, Singh YP, Gupta P and Bamezai RN: Concomitant presence of mutations in mitochondrial genome and p53 in cancer development-a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer 123: 2580-2586, 2008.
15. Ghaffarpour M, Mahdian R, Fereidooni F, Kamalidehghan B, Moazami N and Houshmand M: The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Cancer Cell Int 14: 21, 2014.
16. Prior SL, Griffiths AP and Lewis PD: A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. Br J Dermatol 161: 1067-1071, 2009.
17. Zhou S, KAchap S and Singh KK: Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 18: 287-292, 2003.
18. Shipman R, Schraml P, Moch H, Colombi M, Sauter G, Mihatsch M and Ludwig C: p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer. Int J Oncol 10: 801-806, 1997.
19. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, et al: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709, 1991.
20. Phillips HA, Howard GC and Miller WR: p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer. Br J Cancer 82: 136-141, 2000.
21. Álvarez Kindelán J, López-Beltrán A and Requena Tapia MJ: Molecular biology in bladder cancer. Actas Urol Esp 24: 604-625, 2000 (In Spanish).
22. Lianes P: Biología Molecular del Cáncer de Vejiga. In: Tumores Vesicales Superficiales. Vicente J, Chéchile G and Salvador J (eds). Acción Médica, Madrid, pp47-60, 2000 (In Spanish).
23. Akouchekian M, Houshmand M, Akbari MH, Kamalidehghan B and Dehghan M: Analysis of mitochondrial ND1 gene in human colorectal cancer. J Res Med Sci 16: 50-55, 2011.
24. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724, 2005.
25. Blakely EL, Mitchell AL, Fisher N, Meunier B, Nijtmans LG, Schaefer AM, Jackson MJ, Turnbull DM and Taylor RW: A mitochondrial Cytochrome b mutation causing severe respiratory chain enzyme deficiency in human and yeast. FEBS J 272: 3583-3592, 2005.
26. Jonckheere AI, Smeitink JA and Rodenburg RJ: Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis 35: 211-225, 2012.
27. Czarnecka AM, Kukwa W, Krawczyk T, Scinska A, Kukwa A and Cappello F: Mitochondrial DNA mutations in cancer - from bench to bedside. Front Biosci (Landmark Ed) 15: 437-460, 2010.
28. Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C and Avadhani NG: Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. Embo J 20: 1910-1920, 2001.
29. Matsuyama S, Xu Q, Velours J and Reed JC: The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1: 327-336, 1998.
30. Guney AI, Ergec DS, Tavukcu HH, Koc G, Kirac D, Ulucan K, Javadova D and Turkeri L: Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer. Genet Test Mol Biomarkers 16: 672-678, 2012.
31. Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, Bouvier R, Schägger H and Godinot C: Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23: 759-768, 2002.
32. Meierhofer D, Mayr JA, Foetschl U, Berger A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B and Sperl W: Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis 25: 1005-1010, 2004.
33. Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, Keating MJ and Huang P: Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J 24: 3482-3492, 2005.